Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Foie » Cirrhose du foie 23. Août 2017
Recherche
Gastroplattform
Cirrhose du foie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Hépatite
Cirrhose du foie
Néoplasie
Hypertonie portale
Autres
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 1180  Page précédente Page suivante
   
   Articles 1 - 20 / 23600  
   
Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
PLoS One
Wang L, Feng Y, Ma X, Wang G, Wu H, Xie X, Zhang C, Zhu Q.
PMID: 28820885 [PubMed - in process]


A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients.
Clin Microbiol Infect
Bartoletti M, Giannella M, Lewis R, Caraceni P, Tedeschi S, Paul M, Schramm C, Bruns T, Merli M, Cobos-Trigueros N, Seminari E, Retamar P, Muñoz P, Tumbarello M, Burra P, Torrani Cerenzia M, Barsic B, Calbo E, Maraolo AE, Petrosillo N, Galan-Ladero MA, D'Offizi G, Bar Sinai N, Rodríguez-Baño J, Verucchi G, Bernardi M, Viale P, ESGBIS/BICHROME study group..
PMID: 28818628 [PubMed - as supplied by publisher]


Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.
Lancet Infect Dis
Forns X, Lee SS, Valdes J, Lens S, Ghalib R, Aguilar H, Felizarta F, Hassanein T, Hinrichsen H, Rincon D, Morillas R, Zeuzem S, Horsmans Y, Nelson DR, Yu Y, Krishnan P, Lin CW, Kort JJ, Mensa FJ.
PMID: 28818546 [PubMed - as supplied by publisher]


Deep gray matter iron measurement in patients with liver cirrhosis using quantitative susceptibility mapping: Relationship with pallidal T1 hyperintensity.
J Magn Reson Imaging
Lee S, Nam Y, Jang J, Na GH, Kim DG, Shin NY, Choi HS, Jung SL, Ahn KJ, Kim BS.
PMID: 28815906 [PubMed - as supplied by publisher]


Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats.
Dig Dis Sci
Xu H, Xiong J, Xu J, Li S, Zhou Y, Chen D, Cai X, Ping J, Deng M, Chen J.
PMID: 28815345 [PubMed - as supplied by publisher]


Brain Microstructural Abnormalities in Patients With Cirrhosis Without Overt Hepatic Encephalopathy: A Voxel-Based Diffusion Kurtosis Imaging Study.
AJR Am J Roentgenol
Chen HJ, Liu PF, Chen QF, Shi HB.
PMID: 28813200 [PubMed - as supplied by publisher]


Effects of Taohongsiwu decoction on the expression of α-SMA and TGF-β1 mRNA in the liver tissues of a rat model of hepatic cirrhosis.
Exp Ther Med
Wang T, Wu D, Li P, Zhang K, Tao S, Li Z, Li J.
PMID: 28810560 [PubMed]


Algorithm for Screening of Adrenal Function in Stable Patients with Cirrhosis.
Ann Hepatol
Paz-Delgadillo J, Monreal-Robles R, Villarreal-Pérez JZ, Maldonado-Garza HJ, Bosques-Padilla FJ.
PMID: 28809735 [PubMed - in process]


Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study.
World J Hepatol
Montasser MF, Abdelkader NA, Abdelhakam SM, Dabbous H, Montasser IF, Massoud YM, Abdelmoaty W, Saleh SA, Bahaa M, Said H, El-Meteini M.
PMID: 28804572 [PubMed]


Vitamin D Deficiency Is a Risk Factor for Infections in Patients Affected by HCV-Related Liver Cirrhosis.
Int J Infect Dis
Buonomo AR, Zappulo E, Scotto R, Pinchera B, Perruolo G, Formisano P, Borgia G, Gentile I.
PMID: 28804006 [PubMed - as supplied by publisher]


Outcomes of Transcatheter Versus Surgical Aortic Valve Implantation for Aortic Stenosis in Patients With Hepatic Cirrhosis.
Am J Cardiol
Alqahtani F, Aljohani S, Ghabra A, Alahdab F, Kawsara A, Holmes DR, Alkhouli M.
PMID: 28803656 [PubMed - as supplied by publisher]


Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials.
Lancet Gastroenterol Hepatol
Gane EJ, Pianko S, Roberts SK, Thompson AJ, Zeuzem S, Zuckerman E, Ben-Ari Z, Foster GR, Agarwal K, Laursen AL, Gerstoft J, Gao W, Huang HC, Fitzgerald B, Fernsler D, Li JJ, Grandhi A, Liu H, Su FH, Wan S, Zeng Z, Chen HL, Dutko FJ, Nguyen BT, Wahl J, Robertson MN, Barr E, Yeh WW, Plank RM, Butterton JR, Esteban R.
PMID: 28802816 [PubMed - as supplied by publisher]


Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials.
Lancet Gastroenterol Hepatol
Lawitz E, Buti M, Vierling JM, Almasio PL, Bruno S, Ruane PJ, Hassanein TI, Muellhaupt B, Pearlman B, Jancoriene L, Gao W, Huang HC, Shepherd A, Tannenbaum B, Fernsler D, Li JJ, Grandhi A, Liu H, Su FH, Wan S, Dutko FJ, Nguyen BT, Wahl J, Robertson MN, Barr E, Yeh WW, Plank RM, Butterton JR, Yoshida EM.
PMID: 28802814 [PubMed - as supplied by publisher]


Increased occurrence of brain abscesses in cirrhotic patients: a population-based 3-year follow-up study.
Turk J Gastroenterol
Chen YC, Hung TH, Tseng KC, Tseng CW, Hsieh YH, Tsai CC, Tsai CC.
PMID: 28797986 [PubMed - as supplied by publisher]


Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.
Cochrane Database Syst Rev
Goh ET, Andersen ML, Morgan MY, Gluud LL.
PMID: 28796283 [PubMed - as supplied by publisher]


Factors affecting mortality and resource use for hospitalized patients with cirrhosis: A population-based study.
Medicine (Baltimore)
Charatcharoenwitthaya P, Soonthornworasiri N, Karaketklang K, Poovorawan K, Pan-Ngum W, Chotiyaputta W, Tanwandee T, Phaosawasdi K.
PMID: 28796076 [PubMed - in process]


Oral oxycodone/naloxone for pain control in liver cirrhosis: observational study in patients with symptomatic metastatic hepatocellular carcinoma.
Liver Int
Tovoli F, De Lorenzo S, Samolsky Dekel BG, Piscaglia F, Benevento F, Brandi G, Bolondi L.
PMID: 28792650 [PubMed - as supplied by publisher]


Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study.
Aliment Pharmacol Ther
Cabibbo G, Petta S, Calvaruso V, Cacciola I, Cannavò MR, Madonia S, Distefano M, Larocca L, Prestileo T, Tinè F, Bertino G, Giannitrapani L, Benanti F, Licata A, Scalisi I, Mazzola G, Cartabellotta F, Alessi N, Barbàra M, Russello M, Scifo G, Squadrito G, Raimondo G, Craxì A, Di Marco V, Cammà C, Rete Sicilia Selezione Terapia - HCV (RESIST-HCV)..
PMID: 28791711 [PubMed - as supplied by publisher]


A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: the ITAL-C network study.
J Viral Hepat
Barone M, Iannone A, Shahini E, Ippolito AM, Brancaccio G, Morisco F, Milella M, Messina V, Smedile A, Conti F, Gatti P, Santantonio T, Tundo P, Lauletta G, Napoli N, Masetti C, Termite AP, Francavilla R, Di Leo A, Pesce F, Andriulli A.
PMID: 28787102 [PubMed - as supplied by publisher]


TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis: A meta-analysis update.
J Huazhong Univ Sci Technolog Med Sci
Zhang H, Zhang H, Li H, Zhang H, Zheng D, Sun CM, Wu J.
PMID: 28786052 [PubMed - in process]


   
   Articles 1 - 20 / 23600    Page 1 de 1180  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1